Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.

1. STOCK NEWS:

Pfizer (PFE) agreed to acquire Global Blood Therapeutics (GBT) for $68.50 per share in cash, for a total enterprise value of approximately $5.4B, including debt and net of cash acquired [more]
Nvidia (NVDA) pre-announced preliminary Q2 revenue of $6.7B that missed the consensus $8.1B forecast [more]
Carlyle Group (CG) CEO Kewsong Lee will step down, with Bill Conway named interim CEO [more]
Tesla (TSLA) CEO Elon Musk said the Twitter (TWTR) deal should not proceed if SEC filings are "materially false" [more]
Emerson Electric (EMR) will sell its InSinkErator business to Whirlpool (WHR) for $3B [more]

2. WALL STREET CALLS:

First Solar (FSLR) upgraded, called out by analysts as biggest winner in reconciliation deal [more]
JPMorgan upgraded TPI Composites (TPIC) to Overweight from Neutral [more]
Roku (ROKU) downgraded to Sell from Hold at Pivotal Research [more]
Warner Bros. Discovery (WBD) downgraded to Market Perform from Outperform at Barrington [more]
Western Digital (WDC) downgraded to Hold at Benchmark amid sharp inventory correction [more]

3. AROUND THE WEB:

CVS (CVS) is planning to bid for Signify Health (SGFY), WSJ reports [more]
Tesla (TSLA) signs contracts worth $5B to buy materials for their electric vehicles' lithium batteries from nickel processing companies in Indonesia, Reuters says [more]
Google (GOOGL) has filed two more patent lawsuits against Sonos (SONO), Bloomberg says [more]
The FAA expects Boeing (BA) 787 deliveries to resume in the coming days, Reuters reports [more]
Amazon (AMZN) is in early talks to acquire a 51% stake in Ecom Express, Mint reports [more]

4. MOVERS:

Karuna Therapeutics (KRTX) rises after announcing results from Phase 3 EMERGENT-2 trial [more]
CinCor Pharma (CINC) higher after announcing data for Phase 2 BrigHtn trial evaluating baxdrostat and after reporting quarterly results [more]
W&T Offshore (WTI) increases after reporting quarterly results [more]
uniQure (QURE) falls after reporting quarterly results [more]
Reata Pharmaceuticals (RETA) lower after reporting quarterly results and providing an update on its treatment for Friedrich's ataxia [more]

5. EARNINGS/GUIDANCE:

Palantir (PLTR) fell after guiding FY22 revenue below expectations [more]
Tyson Foods (TSN) reported mixed Q3 results [more]
BioNTech (BNTX) reported downbeat Q2 earnings and revenue [more]
Elanco (ELAN) reported upbeat Q2 results but cut its FY22 adjusted earnings guidance [more]
Stericycle (SRCL) narrowed its FY22 earnings outlook [more]

INDEXES:

The Dow rose 29.07, or 0.089%, to 32,832.54, the Nasdaq lost 13.10, or 0.10%, to 12,644.46, and the S&P 500 declined 5.13, or 0.12%, to 4,140.06.